Adherence to PAP therapy remains a challenge for patients with obstructive sleep apnea. Optional PAP device features and desensitization strategies may help.
A new study shows adults over 60 with sleep apnea achieve improvements in sleepiness, fatigue, depression and quality of life comparable to those in their younger counterparts.
Neuromodulation to treat sleep apnea will be the No. 2 most influential medical innovation for 2018, predict experts at Cleveland Clinic.